We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+25.96%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$91M
AUM Growth
+$8.18M
Cap. Flow
-$8.22M
Cap. Flow %
-9.03%
Top 10 Hldgs %
77.23%
Holding
461
New
74
Increased
130
Reduced
52
Closed
24

Top Buys

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$2.32M
2
KRYS icon
Krystal Biotech
KRYS
+$836K
3
CDNA icon
CareDx
CDNA
+$470K
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$407K
5
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$359K

Top Sells

Rank Stock Value
1
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$13M
2
QDEL icon
QuidelOrtho
QDEL
+$272K
3
TMO icon
Thermo Fisher Scientific
TMO
+$165K
4
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$139K
5
DXCM icon
DexCom
DXCM
+$119K

Sector Composition

Rank Sector Weight
1 Healthcare 12.05%
2 Technology 2.45%
3 Financials 1.96%
4 Industrials 1.54%
5 Consumer Discretionary 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KDNY
251
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$8K 0.01%
666
– –
ATHX
252
DELISTED
Athersys, Inc. Common Stock
ATHX
$8K 0.01%
120
– –
DNKN
253
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$8K 0.01%
116
– –
AIG icon
254
American International
AIG
$42.5B
$7K 0.01%
212
– –
ASML icon
255
ASML
ASML
$596B
$7K 0.01%
19
-2
-10% -$628
BLUE
256
DELISTED
bluebird bio
BLUE
$7K 0.01%
9
– –
BOSC icon
257
Better Online Solutions
BOSC
$31.7M
$7K 0.01%
2,325
– –
BSX icon
258
Boston Scientific
BSX
$68.4B
$7K 0.01%
191
+146
+324% +$5.26K
CI icon
259
Cigna
CI
$78.4B
$7K 0.01%
+38
New +$7.21K
CME icon
260
CME Group
CME
$95.4B
$7K 0.01%
40
– –
CNI icon
261
Canadian National Railway
CNI
$78.5B
$7K 0.01%
81
– –
CTAS icon
262
Cintas
CTAS
$86.6B
$7K 0.01%
104
– –
DVAX
263
DELISTED
Dynavax Technologies
DVAX
$7K 0.01%
750
– –
DXC icon
264
DXC Technology
DXC
$1.91B
$7K 0.01%
+440
New +$7K
EEFT icon
265
Euronet Worldwide
EEFT
$3.19B
$7K 0.01%
68
+14
+26% +$1.29K
ELV icon
266
Elevance Health
ELV
$81.5B
$7K 0.01%
+26
New +$6.94K
GSK icon
267
GSK
GSK
$107B
$7K 0.01%
146
– –
IBM icon
268
IBM
IBM
$213B
$7K 0.01%
+64
New +$7.43K
IEO icon
269
iShares US Oil & Gas Exploration & Production ETF
IEO
$566M
$7K 0.01%
+221
New +$7.1K
IR icon
270
Ingersoll Rand
IR
$33.1B
$7K 0.01%
241
+8
+3% +$226
NEO icon
271
NeoGenomics
NEO
$1.99B
$7K 0.01%
+237
New +$6.57K
OMCL icon
272
Omnicell
OMCL
$1.88B
$7K 0.01%
100
– –
PAYC icon
273
Paycom
PAYC
$7.88B
$7K 0.01%
22
– –
PKG icon
274
Packaging Corp of America
PKG
$22.2B
$7K 0.01%
71
– –
PM icon
275
Philip Morris
PM
$309B
$7K 0.01%
99
+1
+1% +$73
9 10
11
12 13

Similar funds

PPA
Pilgrim Partners Asia Singapore $246M AUM
IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return

HighMark Wealth Management's Q2 2020 Portfolio in Review

As of Q2 2020, HighMark Wealth Management held 461 positions worth $91M, up 9.9% from $82.9M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

HighMark Wealth Management withdrew a net $8.22M in Q2 2020, closing 24 positions and reducing 52 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $104K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.2% a quarter earlier, followed by Technology and Financials.

Against the trend, HighMark Wealth Management opened a new position in Immunomedics Inc worth $2.81M.

  • HighMark Wealth Management's largest Q2 2020 buy was Immunomedics Inc: 79,422 shares worth $2.81M.
  • HighMark Wealth Management added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $407K increase.
  • HighMark Wealth Management's biggest Q2 2020 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $13M.
  • HighMark Wealth Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, selling an estimated $104K.
  • HighMark Wealth Management's ten largest holdings make up 77% of its $91M portfolio in Q2 2020.
  • HighMark Wealth Management opened 74 new positions and closed 24 in Q2 2020.
  • HighMark Wealth Management's portfolio value rose 9.9% quarter-over-quarter to $91M.

Based on HighMark Wealth Management's 13F filing for Q2 2020, filed 22 Jul 2020.